Sysmex America inks distribution deal with Siemens

By LabPulse.com staff writers

August 10, 2020 -- Sysmex America has secured a contract with Siemens Healthineers to distribute that company's Clinitek Novus automated urine chemistry analyzer in North America. The system features dry-pad urine chemistry technology and a cassette test format.

The Clinitek Novus automated urine analyzer from Siemens Healthineers.
The Clinitek Novus automated urine analyzer from Siemens Healthineers. Image courtesy of Siemens.

Siemens' Clinitek Novus automated urine chemistry analyzer features dry-pad urine chemistry technology and a cassette test format, the company said. Sysmex will distribute Clinitek Novus as part of its UN-Series portfolio of urinalysis instruments as well as a standalone offering, according to the firm.

Siemens wins EUA for semiquantitative SARS-CoV-2 antibody test
Siemens Healthineers has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its semiquantitative SARS-CoV-2...
Siemens revenue falls 7% in third quarter
Siemens Healthineers saw its revenue fall 7% in the company's third fiscal quarter due to the impact of the COVID-19 pandemic. The company saw a single-digit...
Sysmex liquid biopsy tracks response in early breast cancer
The SafeSeq personalized liquid biopsy platform is helpful in gauging response to treatment in early-stage breast cancer patients prior to surgery, and...
Sysmex offers SafeSeq breast, head and neck cancer panels
Sysmex Inostics has announced the availability of the company's SafeSeq next-generation sequencing technology for breast cancer and head and neck cancer.
Sysmex, LabCorp extend hematology automation pact
Sysmex America and LabCorp announced they are extending their hematology automation agreement. Sysmex America is providing LabCorp Diagnostics' primary...

Copyright © 2020 LabPulse.com

Last Updated bc 8/11/2020 6:31:56 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email